DCF — TITUS REGIONAL MEDICAL CENTER
Enterprise Value: $-79.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-79.3M
Enterprise Value
$-26.5M
PV of Cash Flows
$-52.8M
PV of Terminal Value
$-85.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $92.4M | $-4.2M | -4.0% | $-8.1M | $-7.3M |
| Year 2 | $95.2M | $-3.3M | -3.0% | $-7.4M | $-6.1M |
| Year 3 | $98.0M | $-2.5M | -2.0% | $-6.6M | $-5.0M |
| Year 4 | $101.0M | $-2.0M | -2.0% | $-6.3M | $-4.3M |
| Year 5 | $104.0M | $-1.8M | -2.0% | $-6.2M | $-3.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-79.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$89.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999996097841476
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5